RE:RE:Net Present Value"Avalyn raised the amount however with a molecule already approved by the fda - their project is an enhanced delivery system for that molecule"
- Avalyn targets the lungs. CZO's treatment could be used outside the lungs too. Dr. Ask said delivery systems could be made. His presentation said 4/10 deaths worldwide are also due to fibrosis.
- COVID also wasn't around when Avalyn raised the C$80 million. McMaster was to investigate PGX-YBG with an anti-inflammatory already used for COVID patients according to a news release. Perhaps this could provide an accelerated path to approval compared to IPF.
- PGX-YBG can further be used as a delivery platform for the delivery of other drugs beyond fibrosis that target macrophages.